Delivery Order SPE2DB24D2013-SPE2DB25FCGQK
Award Date
10/16/24
Potential Completion Date
10/17/24
Potential Value
$30K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,478.03 firm-fixed-price delivery order is for the supply of ADCIRCA 20 MG TABLET 60S, a medication used to treat pulmonary arterial hypertension. The contract has an ultimate completion date of January 24, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,202.50 firm-fixed-price delivery order is for the supply of ADCIRCA 20 MG TABLET 60S, a pharmaceutical product. The contract is not set aside and has an ultimate completion date of May 9, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $7,494.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of ADCIRCA 20 MG TABLET 60S, a pharmaceutical product, with a performance period extending to May 12, 2025. The contract is a Firm Fixed Price, non-set-aside award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $19,004.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of ADCIRCA 20 MG TABLET 60S, a medication used in the treatment of pulmonary arterial hypertension. The contract has an ultimate completion date of March 21, 2025 and is a Firm Fixed Price arrangement. This award is not associated with a set-aside...
This federal contract award, valued at $16,674.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ADCIRCA 20 MG TABLET 60S, a pharmaceutical product, with a completion date of September 30, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $45,397.09, is for the supply of ADCIRCA 20 MG TABLET 60S, a medication used to treat pulmonary arterial hypertension. The contract is a firm fixed-price, delivery order type, with a period of performance through March 21, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of ADCIRCA 20 MG TABLET 60S, a medication used to treat pulmonary arterial hypertension. The firm-fixed-price delivery order, valued at $4,997.44, has an ultimate completion date of June 28, 2024. This contract award is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $15,183.46, is for the delivery of ADCIRCA 20 MG TABLET 60S, a medication, to support federal medical and healthcare needs. The contract is a delivery order, with a firm fixed price pricing type, and has an ultimate completion date of April 30, 2025. It is not designated as a set-aside contract, indicating open competition....
This federal contract award, valued at $14,916.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ADCIRCA 20 MG TABLET 60S, a medication, with a completion date of March 19, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,192.71 firm fixed-price delivery order contract, which runs through March 2025, is for the supply of ADCIRCA 20 MG TABLET 60S, a pharmaceutical product. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a...